Company Nutriband Inc.

Equities

NTRB

US67092M2089

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 21:00:00 17/05/2024 BST 5-day change 1st Jan Change
4.47 USD -5.30% Intraday chart for Nutriband Inc. +33.04% +92.67%

Business Summary

Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Sales per Business

USD in Million2023Weight2024Weight Delta
Pocono Pharmaceuticals
92.1 %
2 85.9 % 2 92.1 % +7.54%
4P Therapeutics
7.9 %
0 14.1 % 0 7.9 % -43.89%

Sales per region

USD in Million2023Weight2024Weight Delta
United States
100.0 %
2 100.0 % 2 100.0 % +0.27%

Managers

Managers TitleAgeSince
Founder 35 31/12/11
Founder 52 31/12/11
Director of Finance/CFO 76 30/07/18
Chief Tech/Sci/R&D Officer 38 31/01/18
Chief Tech/Sci/R&D Officer 55 14/05/18
Chief Operating Officer 59 31/07/18
Chief Tech/Sci/R&D Officer 60 01/08/18
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Founder 52 31/12/11
Director/Board Member 48 30/06/18
Founder 35 31/12/11
Director/Board Member 39 30/06/18
Director/Board Member 53 13/06/19
Director/Board Member 36 20/01/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,979,870 6,869,367 ( 62.56 %) 10,000 ( 0.0911 %) 62.56 %

Shareholders

NameEquities%Valuation
1,761,667 22.49 % 6 M $
T.I.I. - Jetservices Lda. (Zona Franca da Madeira)
17.20 %
1,347,524 17.20 % 5 M $
820,418 10.47 % 3 M $
Vanguard Group, Inc. (Subfiler)
1.108 %
86,800 1.108 % 316 820 $
Geode Capital Management LLC
0.7477 %
58,571 0.7477 % 213 784 $
Alan Smith
0.6242 %
48,893 0.6242 % 178 459 $
36,612 0.4674 % 133 634 $
RBC CMA LLC
0.4476 %
35,060 0.4476 % 127 969 $
26,250 0.3351 % 95 813 $
17,266 0.2204 % 63 021 $
NameEquities%Valuation
Citadel Securities GP LLC
-
113,189 - 87 721 $
Clear Street LLC
-
3,380 - 2 620 $
UBS Securities LLC
-
196 - 152 $

Company contact information

Nutriband, Inc.

121 South Orange Avenue Suite 1500

32801, Orlando

+407 377 6695

http://www.nutriband.com
address Nutriband Inc.(NTRB)
  1. Stock Market
  2. Equities
  3. NTRB Stock
  4. Company Nutriband Inc.